Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 147086-81-5
2. (4s,6s)-6-methyl-7,7-dioxo-5,6-dihydro-4h-thieno[2,3-b]thiopyran-4-ol
3. Jj8mbd49ur
4. (4s,6s)-5,6-dihydro-6-methyl-4h-thieno[2,3-b]thiopyran-4-ol 7,7-dioxide
5. 5,6-dihydro-6-methyl-4h-thieno(2,3-b)thiopyran-4-ol 7,7-dioxide, (4s,6s)-
6. (4s,6s)-5,6-dihydro-6-methyl-4h-thieno(2,3-b)thiopyran-4-ol 7,7-dioxide
7. Unii-jj8mbd49ur
8. (4s,6s)-5,6-dihydro-4-hydroxy-6-methylthieno[2,3-b]thiopyran-7,7-dioxide
9. Ec 417-290-3
10. Dsstox_cid_31435
11. Dsstox_rid_97321
12. Dsstox_gsid_57646
13. Chembl3189041
14. Dtxsid3057646
15. Schembl12315840
16. Amy8619
17. Zinc5752130
18. Tox21_113917
19. Akos015898773
20. Ac-6911
21. (4s,6s)-4-hydroxy-6-methyl-5,6-dihydro-4h-thieno[2,3-b]thiopyran7,7-dioxide
22. Ncgc00262921-01
23. Ts-00482
24. Cas-147086-81-5
25. A884465
26. Q27281532
27. (3s,5s)-3-methyl-2,2-dioxo-2$l^{6},9-dithiabicyclo[4.3.0]nona-7,10-die N-5-ol
28. (4s)-5,6-dihydro-4-hydroxy-6alpha-methyl-4h-thieno[2,3-b]thiopyran 7,7-dioxide
29. (4s,6s)-5,6-dihydro-4-hydroxy-6-methylthieno(2,3-b)thiopyran 7,7-dioxide
30. 4h-thieno(2,3-b)thiopyran-4-ol, 5,6-dihydro-6-methyl-, 7,7-dioxide, (4s,6s)-
31. 4h-thieno(2,3-b)thiopyran-4-ol, 5,6-dihydro-6-methyl-, 7,7-dioxide, (4s-trans)-
Molecular Weight | 218.3 g/mol |
---|---|
Molecular Formula | C8H10O3S2 |
XLogP3 | 0.9 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 0 |
Exact Mass | 218.00713652 g/mol |
Monoisotopic Mass | 218.00713652 g/mol |
Topological Polar Surface Area | 91 Ų |
Heavy Atom Count | 13 |
Formal Charge | 0 |
Complexity | 293 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
ABOUT THIS PAGE
99
PharmaCompass offers a list of 147086-81-5 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right 147086-81-5 manufacturer or 147086-81-5 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred 147086-81-5 manufacturer or 147086-81-5 supplier.
PharmaCompass also assists you with knowing the 147086-81-5 API Price utilized in the formulation of products. 147086-81-5 API Price is not always fixed or binding as the 147086-81-5 Price is obtained through a variety of data sources. The 147086-81-5 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 147086-81-5 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 147086-81-5, including repackagers and relabelers. The FDA regulates 147086-81-5 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 147086-81-5 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 147086-81-5 supplier is an individual or a company that provides 147086-81-5 active pharmaceutical ingredient (API) or 147086-81-5 finished formulations upon request. The 147086-81-5 suppliers may include 147086-81-5 API manufacturers, exporters, distributors and traders.
click here to find a list of 147086-81-5 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A 147086-81-5 DMF (Drug Master File) is a document detailing the whole manufacturing process of 147086-81-5 active pharmaceutical ingredient (API) in detail. Different forms of 147086-81-5 DMFs exist exist since differing nations have different regulations, such as 147086-81-5 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 147086-81-5 DMF submitted to regulatory agencies in the US is known as a USDMF. 147086-81-5 USDMF includes data on 147086-81-5's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 147086-81-5 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 147086-81-5 suppliers with USDMF on PharmaCompass.
147086-81-5 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 147086-81-5 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 147086-81-5 GMP manufacturer or 147086-81-5 GMP API supplier for your needs.
A 147086-81-5 CoA (Certificate of Analysis) is a formal document that attests to 147086-81-5's compliance with 147086-81-5 specifications and serves as a tool for batch-level quality control.
147086-81-5 CoA mostly includes findings from lab analyses of a specific batch. For each 147086-81-5 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
147086-81-5 may be tested according to a variety of international standards, such as European Pharmacopoeia (147086-81-5 EP), 147086-81-5 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (147086-81-5 USP).